Delaware
|
333-123365
|
20-1602779
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
No.)
|
Large
accelerated filer ¨
|
Accelerated
filer
¨
|
Non-accelerated
filer ¨ (Do not
check if a smaller reporting company)
|
Smaller
reporting company
ý
|
PAGE
|
||
PART I
|
||
Item 1.
|
3
|
|
Item
1A.
|
14
|
|
Item
1B.
|
19
|
|
Item 2.
|
20
|
|
Item 3.
|
20
|
|
Item 4.
|
20
|
|
PART II
|
||
Item 5.
|
21
|
|
Item 6.
|
21
|
|
Item 7.
|
22
|
|
Item
7A.
|
28
|
|
Item
8.
|
28
|
|
Item 9.
|
28
|
|
Item
9A(T).
|
28
|
|
Item
9B.
|
29
|
|
PART III
|
||
Item 10.
|
30
|
|
Item 11.
|
32
|
|
Item 12.
|
36
|
|
Item 13.
|
37
|
|
Item 14.
|
37
|
|
PART IV
|
||
Item 15.
|
38
|
|
|
·
|
They
kill a wide range of infectious microorganism, including
MRSA;
|
|
·
|
They
minimize harmful effects to people and do not cause skin, eye, pulmonary,
oral or dermal irritation;
|
|
·
|
They
are non-corrosive (EnviroTru®/EnviroTru®
1453 are included in the Boeing Qualified Products List (QPL) and conform
with AMS-1452A, 1453 & D6-7127 Aircraft Corrosion Specifications);
and
|
·
|
Surface
care products - disinfectants, sanitizers and cleaners (including
wipes);
|
·
|
Animal
care products - skin and hoof care treatment and animal
shampoo;
|
·
|
Personal
care products – antimicrobial hand soaps, hand sanitizers and facial
scrubs (including wipes); and
|
·
|
Geo-Biocides
– biocides for use in the oil and gas
industry.
|
·
|
EnviroTru®
Disinfectant
& Cleaner Deodorizer, which is a
multi-purpose, ready-to-use disinfectant, sanitizer and deodorizing
cleaner for use on hard surfaces. EnviroTru® is
effective against numerous organisms without causing any adverse effects
to surfaces, humans or the environment. EnviroTru® is
registered by the Environmental Protection Agency (EPA) and meets EPA
requirements for Toxicity Category IV (minimal effects noted, no
precautionary or first aid statements required; no harmful dermal, ocular,
inhalation or ingestion effects). EnviroTru®
also conforms to AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for
non-corrosion and materials compatibility. EnviroTru®
has no special handling requirements, does not require protective
clothing, gloves or special ventilation and is
non-flammable.
|
·
|
EnviroTru®
1453 Disinfectant
& Cleaner Deodorizer, which is a
multi-purpose, ready-to-use disinfectant, sanitizer and deodorizing
cleaner for use on aircraft hard surfaces, including exterior and interior
surfaces such as cabins, toilets, sinks, faucets, counter tops and luggage
compartments. EnviroTru®1453
conforms to AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for
non-corrosion and materials compatibility. EnviroTru®1453
is registered by the Environmental Protection Agency (EPA) and meets EPA
requirements for Toxicity Category IV (minimal effects noted, no
precautionary or first aid statements required; no harmful dermal, ocular,
inhalation or ingestion effects). EnviroTru®1453
has no special handling requirements, does not require protective
clothing, gloves or special ventilation and is
non-flammable.
|
·
|
SurfaceTru™ Deodorizing
Cleaner, which is a powerful, multi-purpose cleaner and deodorizer
that’s safe for use on a variety of surfaces. SurfaceTru™ is
effective for removing dirt and grime and is gentle to application
surfaces, safe for the user and friendly to the environment. It has no
special handling requirements, does not require protective clothing,
gloves or special ventilation and is
non-flammable.
|
·
|
SurfaceTru™
Cleaning & Deodorizing Wipes, which are powerful cleaning and
deodorizing wipes that are packaged in their own individual foil wrappers
for easy portability. Each wipe opens to a large, 9” x 8” durable cloth
with a smooth finish that can be conveniently used on a variety of
surfaces. SurfaceTru™ Wipes can be carried with you for use when an
immediate need for an effective, yet gentle cleaner
arises.
|
·
|
Electrostatic
Sprayers. In addition to the foregoing products,
we also market electrostatic sprayers produced by Electrostatic Spraying
Systems, Inc. (“ESS”)
which may be used to apply our liquid surface care products to the target
surfaces. Electrostatic sprayers provide superior spray coverage by more
effectively dispensing solutions compared to conventional sprayers; tests
have demonstrated 4-10 times better coverage. Electrostatic sprayers
operate by producing highly charged spray droplets using a unique embedded
induction electrode design. This induction charging results in spray
droplets that have a force of attraction that is 75 times that of gravity.
This means droplets will reverse direction and move upwards, against
gravity, to coat hidden surfaces, and wrap around objects resulting in
complete, even coverage of the target. When using an electrostatic sprayer
it is possible to deliver ESI’s liquid disinfectants and cleaners to
difficult to reach locations that may harbor disease-causing
microorganisms.
|
|
·
|
make
it difficult for us to make payments on our Notes and other
indebtedness;
|
|
·
|
make
it difficult for us to obtain financing for working capital, acquisitions
or other purposes on favorable terms, if at
all;
|
|
·
|
make
us more vulnerable to industry downturns and competitive pressures;
and
|
|
·
|
limit
our flexibility in planning for, or reacting to changes in, our
business.
|
|
·
|
regulatory
actions;
|
|
·
|
variations
in our operating results;
|
|
·
|
announcements
of technological innovations, new products or product enhancements,
strategic alliances or significant agreements by us or by our
competitors;
|
|
·
|
recruitment
or departure of key personnel;
|
|
·
|
litigation,
legislation, regulation or technological developments that adversely
affect our business;
|
|
·
|
changes
in the estimates of our operating results or changes in recommendations by
any securities analysts that elect to follow our common stock;
and
|
|
·
|
market
conditions in our industry, the industries of our customers and the
economy as a whole.
|
MARKET
FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
PURCHASES OF EQUITY SECURITIES.
|
High
|
Low
|
|||||||
Period
from January 1, 2009 to March 31, 2009
|
$ | 0.30 | $ | 0.15 | ||||
Period
from October 1, 2008 to December 21, 2008
|
$ | 0.73 | $ | 0.24 | ||||
Period
from July 1, 2008 to September 30, 2008
|
$ | 0.84 | $ | 0.50 | ||||
Period
from April 1, 2008 to June 30, 2008
|
$ | 0.90 | $ | 0.50 | ||||
Period
from January 1, 2008 to March 31, 2008
|
$ | 1.01 | $ | 0.55 | ||||
Period
from October 1, 2007 to December 31, 2007
|
$ | 2.25 | $ | 0.91 | ||||
Period
from July 1, 2007 to September 30, 2007
|
$ | 2.25 | $ | 1.60 | ||||
Period
from April 1, 2007 to June 30, 2007
|
$ | 3.00 | $ | 1.80 |
SELECTED
FINANCIAL DATA.
|
MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATION.
|
·
|
Surface
care products - disinfectants, sanitizers and cleaners (including
wipes);
|
·
|
Animal
care products - skin and hoof care treatment and animal
shampoo;
|
·
|
Personal
care products – antimicrobial hand soaps, hand sanitizers and facial
scrubs (including wipes); and
|
·
|
Geo-Biocides
– biocides for use in the oil and gas
industry.
|
|
·
|
They
kill a wide range of infectious microorganism, including
MRSA;
|
|
·
|
They
minimize harmful effects to people and do not cause skin, eye, pulmonary,
oral or dermal irritation;
|
|
·
|
They
are non-corrosive (EnviroTru®/EnviroTru®
1453 are included in the Boeing Qualified Products List (QPL) and conform
with AMS-1452A, 1453 & D6-7127 Aircraft Corrosion Specifications);
and
|
·
|
Surface
care products - disinfectants, sanitizers and cleaners (including
wipes);
|
·
|
Animal
care products - skin and hoof care treatment and animal
shampoo;
|
·
|
Personal
care products – antimicrobial hand soaps, hand sanitizers and facial
scrubs (including wipes); and
|
·
|
Geo-Biocides
– biocides for use in the oil and gas
industry.
|
·
|
EnviroTru®
Disinfectant
& Cleaner Deodorizer, which is a
multi-purpose, ready-to-use disinfectant, sanitizer and deodorizing
cleaner for use on hard surfaces. EnviroTru® is
effective against numerous organisms without causing any adverse effects
to surfaces, humans or the environment. EnviroTru® is
registered by the Environmental Protection Agency (EPA) and meets EPA
requirements for Toxicity Category IV (minimal effects noted, no
precautionary or first aid statements required; no harmful dermal, ocular,
inhalation or ingestion effects). EnviroTru®
also conforms to AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for
non-corrosion and materials compatibility. EnviroTru®
has no special handling requirements, does not require protective
clothing, gloves or special ventilation and is
non-flammable.
|
·
|
EnviroTru®
1453 Disinfectant
& Cleaner Deodorizer, which is a
multi-purpose, ready-to-use disinfectant, sanitizer and deodorizing
cleaner for use on aircraft hard surfaces, including exterior and interior
surfaces such as cabins, toilets, sinks, faucets, counter tops and luggage
compartments. EnviroTru®1453
conforms to AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for
non-corrosion and materials compatibility. EnviroTru®1453
is registered by the Environmental Protection Agency (EPA) and meets EPA
requirements for Toxicity Category IV (minimal effects noted, no
precautionary or first aid statements required; no harmful dermal, ocular,
inhalation or ingestion effects). EnviroTru®1453
has no special handling requirements, does not require protective
clothing, gloves or special ventilation and is
non-flammable.
|
·
|
SurfaceTru™ Deodorizing
Cleaner, which is a powerful, multi-purpose cleaner and deodorizer
that’s safe for use on a variety of surfaces. SurfaceTru™ is
effective for removing dirt and grime and is gentle to application
surfaces, safe for the user and friendly to the environment. It has no
special handling requirements, does not require protective clothing,
gloves or special ventilation and is
non-flammable.
|
·
|
SurfaceTru™
Cleaning & Deodorizing Wipes, which are powerful cleaning and
deodorizing wipes that are packaged in their own individual foil wrappers
for easy portability. Each wipe opens to a large, 9” x 8” durable cloth
with a smooth finish that can be conveniently used on a variety of
surfaces. SurfaceTru™ Wipes can be carried with you for use when an
immediate need for an effective, yet gentle cleaner
arises.
|
·
|
Electrostatic
Sprayers. In addition to the foregoing products,
we also market electrostatic sprayers produced by Electrostatic Spraying
Systems, Inc. (“ESS”)
which may be used to apply our liquid surface care products to the target
surfaces. Electrostatic sprayers provide superior spray coverage by more
effectively dispensing solutions compared to conventional sprayers; tests
have demonstrated 4-10 times better coverage. Electrostatic sprayers
operate by producing highly charged spray droplets using a unique embedded
induction electrode design. This induction charging results in spray
droplets that have a force of attraction that is 75 times that of gravity.
This means droplets will reverse direction and move upwards, against
gravity, to coat hidden surfaces, and wrap around objects resulting in
complete, even coverage of the target. When using an electrostatic sprayer
it is possible to deliver ESI’s liquid disinfectants and cleaners to
difficult to reach locations that may harbor disease-causing
microorganisms.
|
Year
Ended March 31,
|
||||||||
Products
|
2009
|
2008
|
||||||
SurfaceTru®
|
0.79 | % | - | |||||
SurfaceTru®
Cleaning & Deodorizing Wipes
|
29.63 | % | 46.85 | % | ||||
EnviroTru®
and EnviroTru 1453®
|
45.41 | % | 52.00 | % | ||||
EquineTru®
|
4.63 | % | 1.15 | % | ||||
Electro-Satic
Sprayer
|
19.54 | % | - |
Contractual Obligations
|
Total
|
Less
than
1
year
|
1-3
years
|
4-5
years
|
After
5
years
|
|||||||||||||||
Office
Lease
|
$ | 35,400 | $ | 35,400 | — | — | — | |||||||||||||
Laboratory
Lease (1)
|
— | — | — | — | — | |||||||||||||||
Total
Contractual Cash Obligations
|
$ | 35,400 | $ | 35,400 | — | — | — |
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK.
|
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA.
|
ITEM 9.
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE.
|
ITEM 9A
(T).
|
CONTROLS
AND PROCEDURES.
|
|
·
|
Pertain
to the maintenance of records that in reasonable detail accurately and
fairly reflect the transactions and dispositions of the Company’s
assets;
|
|
·
|
Provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of the financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures are
being made only in accordance with authorizations of management and the
Board of Directors; and
|
|
·
|
Provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the Company’s assets that
could have a material effect on the financial
statements.
|
ITEM
9B.
|
OTHER
INFORMATION.
|
ITEM
10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE
GOVERNANCE.
|
Name
|
Age
|
Position(s)
|
J.
Lloyd Breedlove
|
61
|
President,
Chief Executive Officer, Chairman of the Board of
Directors
|
Stephen
Hoelscher
|
50
|
Chief
Financial Officer, Secretary, Director
|
Paul
S. Malchesky
|
62
|
Chief
Science Officer, EnviroSystems
|
Jeff
Savino
|
55
|
Vice
President, Marketing and Sales,
EnviroSystems
|
ITEM 11.
|
EXECUTIVE
COMPENSATION.
|
|
Nonqualified
|
||||||||||||||||||||||||||||||||
|
Non-Equity
|
Deferred
|
All
|
||||||||||||||||||||||||||||||
|
Stock
|
Option
|
Incentive
Plan
|
Compensation
|
Other
|
||||||||||||||||||||||||||||
Name
and Principal
|
Salary
|
Bonus
|
Awards
|
Awards
|
Compensation
|
Earnings
|
Compensation
|
Total
|
|||||||||||||||||||||||||
Position
|
Year
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
||||||||||||||||||||||||
(A)
|
|||||||||||||||||||||||||||||||||
J.
Lloyd Breedlove,
|
2009
|
$
|
260,041
|
(1)
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
260,041
|
|||||||||||||||
Pres.,
CEO and
|
2008
|
$
|
260,041
|
$
|
-0-
|
$
|
-0-
|
$
|
242,060
|
(2)
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
502,101
|
|||||||||||||||
Director
(1)
|
|||||||||||||||||||||||||||||||||
Stephen
Hoelscher,
|
2009
|
$
|
140,016
|
(2)
|
$
|
-0-
|
$
|
-0-
|
$
|
62,885
|
(4)
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
202,901
|
||||||||||||||
CFO,
Secretary and Director
|
2008
|
$
|
140,016
|
$
|
-0-
|
$
|
-0-
|
$
|
62,885
|
(4)
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
$
|
202,901
|
|||||||||||||||
Name
|
Exercisable
(Vested)
|
Unexercisable
(Uvested)
|
Option Exercise Price
($)
|
Option
Expiration Date
|
|||||||||
J.
Lloyd Breedlove
|
750,000 | (1) | -0- | $ | 2.50 |
01/10/2011
|
|||||||
Stephen
Hoelscher
|
150,000 | (2) | 50,000 | $ | 2.20 |
12/17/2016
|
March
31,
|
March
31,
|
|||||||
Name
|
2009
|
2008
|
||||||
J.
Lloyd Breedlove
|
-0-
|
250,000
|
||||||
Stephen
Hoelscher
|
50,000
|
50,000
|
DIRECTOR
COMPENSATION
|
||||||||||||||||||||||||||||
Name
|
Fees
Earned or Paid in Cash
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan Compensation
($)
|
Non-Qualified
Deferred Compensation Earnings
($)
|
All
Other Compensation
($)
|
Total
($)
|
|||||||||||||||||||||
J.
Lloyd Breedlove (1)
|
— | — | — | — | — | — | — | |||||||||||||||||||||
Stephen
Hoelscher (1)
|
— | — | — | — | — | — | — | |||||||||||||||||||||
Stephen
A. Schneider (2)
|
— | — | — | — | — | — | — | |||||||||||||||||||||
Paul
A. Boyer (2)
|
— | — | $ | 2,088 | — | — | — | $ | 2,088 | |||||||||||||||||||
David
V. Gilroy (2)
|
— | — | $ | 2,088 | — | — | — | $ | 2,088 |
Plan
Category
|
Number
of
Securities
to
be
issued upon
exercise
of
outstanding
options
(a)
|
Weighted-
average
exercise
price
of
outstanding
(b)
|
Number
of Securities
remaining
for future issuance
under
equity compensation
plans
(excluding securities
reflected
in column (a))
(c)
|
|||||||||
Equity
compensation plans approved by security holders
|
1,390,000 | $ | 2.34 | 2,310,000 | * | |||||||
Equity
compensation plans not approved by security holders
|
— | — | — | |||||||||
Total
|
1,390,000 | $ | 2.34 | 2,310,000 |
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS.
|
Name
and address of Beneficial Owner
|
Amount
(1)
|
Percent
of
Class
|
||||||
Directors
and Named Executive Officers (2):
|
||||||||
J.
Lloyd Breedlove (3)
|
1,128,545 | 6.4 | % | |||||
Stephen
Hoelscher (4)
|
284,024 | 1.7 | % | |||||
All
directors and named executive officers as a group (two
persons)
|
1,413,569 | 8.1 | % | |||||
Other
5% or Greater Beneficial Owners
|
||||||||
The
Ferguson Living Trust UDT 8/13/74 (5)
2100
Gold Street
San
Jose, CA 95164
|
2,915,562 | 15.0 | % | |||||
Alma
and Gabriel Elias (6)
509
Spring Avenue
Elkins
Park, PA 19027
|
1,485,000 | 8.7 | % | |||||
Other
Stockholders
|
||||||||
MV
Nanotech Corp. (7)
600
Congress Avenue, Suite 1220
Austin,
TX 78701
|
241,753 | 1.4 | % | |||||
ANPG
Lending LLC (8)
c/o
Romulus Holdings
2200
Fletcher Avenue
Fort
Lee, NJ 07024
|
3,224,137 | 4.9 | % |
(1)
|
Beneficial
ownership is calculated based on 16,503,654 shares of our common stock
issued and outstanding as of June 29, 2009. Beneficial ownership is
determined in accordance with Rule 13d-3 of the Securities and
Exchange Commission. The number of shares beneficially owned by a person
includes shares of common stock subject to options or warrants held by
that person that are currently exercisable or exercisable within 60 days
following the date hereof. The shares issuable pursuant to those options
or warrants are deemed outstanding for computing the percentage
ownership of the person holding these options and warrants but are not
deemed outstanding for the purposes of computing the percentage
ownership of any other person. The persons and entities named in the table
have sole voting and sole investment power with respect to the shares set
forth opposite the stockholder's name, subject to community property laws,
where applicable.
|
(2)
|
The
address for the directors and named executive officers is c/o Anpath
Group, Inc., 116 Morlake Drive, Suite 201, Mooresville, North Carolina
28117.
|
(3)
|
Includes
200,775 common stock shares, 750,000 shares of common stock issuable upon
the exercise of options at an exercise price of $2.50 per share and
116,146 shares of common stock issuable upon the exercise of options
at an exercise price of $0.88 per share. Also includes 62,624 shares of
common stock issuable upon exercise of options to purchase shares of
EnviroSystems preferred stock, using a conversion ratio of 1.956994 shares
of our common stock for each share of EnviroSystems preferred stock
issuable upon exercise. Mr. Breedlove holds options to purchase
32,000 shares of EnviroSystems preferred stock which are exercisable to
purchase up to 62,624 shares of our common stock based on the conversion
ratio. Such number of shares was determined assuming the exercise of all
options and warrants to purchase EnviroSystems preferred stock. In the
event such options and/or warrants expire without being exercised, then
any shares of common stock issuable upon exercise shall be distributed
pro-rata among the EnviroSystems preferred stockholders. In the event of
such a pro-rata distribution, Mr. Breedlove would be eligible to
receive additional shares of common stock. This amount does not include
750,000 shares of common stock issuable upon the exercise of options at an
exercise price of $0.24 per share which have not
vested.
|
(4)
|
Includes
110,540 common stock shares, 166,666 shares of common stock issuable upon
the exercise of options at an exercise price of $2.20 per share and
6,818 shares of common stock issuable upon the exercise of options at
an exercise price of $0.88 per share. Mr. Hoelscher is a 5% owner and
the CFO of Mastodon Ventures, Inc. Such shares do not include the shares
of common stock issuable upon exercise of warrants to purchase common
stock held by MV Nanotech Corp, a subsidiary of Mastodon Ventures, Inc.
This amount does not include 33,334 shares of common stock issuable upon
the exercise of options at an exercise price of $2.20 per share which have
not vested. This amount does not include 200,000 shares of common stock
issuable upon the exercise of options at an exercise price of $0.24 per
share which have not vested.
|
(5)
|
Includes
2,500,000 shares of common stock issuable upon the exercise of warrants to
purchase common stock. Also includes 415,562 shares of common stock issued
in exchange for shares of EnviroSystems preferred
stock.
|
(6)
|
Includes
1,000,000 shares of common stock owned by Alma and Gabriel Elias and also
includes 485,000 shares of common stock owned by Wholesale Realtors
Supply. Gabriel Elias has voting control over the shares held by Wholesale
Realtors Supply.
|
(7)
|
Includes
241,753 shares of common stock issuable upon the exercise of warrants held
by MV Nanotech Corp.
|
(8)
|
Such
shares include 735,000 shares of common stock out of a total of
approximately 3,224,137 shares of common stock issuable upon the
conversion of convertible promissory notes (the “Notes”) and 1,500,000
issuable upon the exercise of warrants (the “Warrants”). The Notes have an
aggregate principal balance of $1,500,000 and are convertible into shares
of common stock at a price of $0.87 per share, subject to adjustment
pursuant to anti-dilution provisions in the Notes. The Warrants have an
exercise price of $0.87 per share, subject to adjustment pursuant to
anti-dilution provisions in the Warrants. The Notes and Warrants have
limits on exercise and conversion. According to the terms of the Notes and
the Warrants held by ANPG Lending LLC, it is prohibited from converting
the Notes or exercising its Warrants if after such exercise or conversion,
ANPG Lending LLC’s percentage ownership of common stock would exceed
4.9%. If there were no such restrictions in the Notes and Warrants, and
ANPG Lending LLC had the right to exercise such Notes and Warrants for all
3,224,137 shares, ANPG Limited LLC would be deemed to own approximately
16.3% of our common stock.
|
ITEM
13.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE.
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES.
|
2009
|
2008
|
|||||||
Audit
Fees
|
$ | 65,130 | $ | 45,844 | ||||
Audit
Related Fees
|
— | — | ||||||
Tax
Fees
|
— | — | ||||||
All
Other Fees
|
— |
—
|
EXHIBITS,
FINANCIAL STATEMENT SCHEDULES.
|
(a) |
(1)
|
Financial Statements. |
(2)
|
Financial Statement Schedules |
(3)
|
The
exhibits listed below are filed as part of this annual
report.
|
Exhibit
Number
|
Exhibit Description
|
|
3.1
|
Composite
Certificate of Incorporation (11)
|
|
3.2
|
By-Laws
(1)
|
|
4.1
|
Specimen
Certificate of Common Stock (1)
|
|
4.2
|
Form of
Warrant (5)
|
|
4.3
|
Warrant,
dated July 6, 2007 (8)
|
|
4.4
|
Form of
Note (10)
|
|
4.5
|
Form of
Warrant (10)
|
|
10.1
|
2004
Equity Compensation Plan (1)
|
|
10.2
|
Securities
Purchase Agreement, dated as of October 31, 2005 between MV Nanotech
Corp. and Telecomm Sales Network, Inc. (2)
|
|
10.3
|
Agreement
and Plan of Merger, dated as of November 11, 2005 by and between
Telecomm, TSN Acquisition Corporation and EnviroSystems, Inc. (Nonmaterial
schedules and exhibits identified in the Agreement and Plan of Merger have
been omitted pursuant to Item 601b.2 of Regulation S-K. Telecomm
Sales Network, Inc. agrees to furnish supplementally to the Commission
upon request by the Commission a copy of any omitted schedule or exhibit.)
(3)
|
|
10.4
|
Escrow
and Lock-Up Agreement, dated as of November 11, 2005 by and between
Telecomm, Daniel Ferguson, as shareholder agent, EnviroSystems and Jerold
K. Levien, Esq. as escrow agent.(4)
|
|
10.5
|
Form of
Registration Rights Agreement between Telecomm Sales Network, Inc. and the
other signatories thereto. (5)
|
|
10.6
|
Commercial
Lease Agreement dated June 6, 2006 by and between Morlake Executive
Suites and EnviroSystems, Inc. (5)
|
|
10.7
|
Telecomm
Sales Network, Inc. 2006 Stock Incentive Plan (5)+
|
|
10.8
|
Form of
Incentive Stock Option Agreement (5)+
|
|
10.9
|
Form of
Non-Qualified Stock Option Agreement (5)+
|
|
10.10
|
Form of
Restricted Stock Agreement (5)+
|
|
10.11
|
Employment
Agreement made as of January 19, 2006 between Telecomm Sales Network,
Inc. and J. Lloyd Breedlove(4)
|
|
10.12
|
Manufacturing
Agreement dated as of August 1, 2006 between EnviroSystems, Inc. and
Minntech Corporation (6) *
|
|
10.13
|
Intellectual
Property Assignment Agreement between EnviroSystems, Inc. American
Children’s Foundation, Richard H. Othus, Andrew D.B. Lambie and Cascade
Chemical Corporation.(9)
|
|
10.14
|
Consent
Agreement and Final Order with United States Environmental Protection
Agency (6)
|
|
10.15
|
Securities
Purchase Agreement dated as of March 7, 2007 between MV Nanotech
Corp., the Singer Children’s Management Trust and, solely with respect to
sections 4 and 8, Anpath Group, Inc.
|
|
10.16
|
Settlement
Agreement dated as of July 6, 2007 by and among Anpath Group, Inc.,
MV Nanotech Corp. and The Ferguson Living Trust UTD 8/13/74 and Daniel
Ferguson in his capacity as Shareholder Agent (8)
|
|
10.17
|
Lock-Up
Agreement made and entered into as of July 6, 2007
(8)
|
|
10.18
|
Loan
and Security Agreement dated as of January 8, 2008 by and between
Anpath Group, Inc. and ANPG Lending LLC (without exhibits or
schedules).(10)
|
|
10.19
|
Securities
Repurchase Agreement dated as of January 8, 2008 by and between
Anpath Group, Inc, ANPG Lending LLC and the Singer Children’s Management
Trust (without exhibits or schedules) (10).
|
|
10.20
|
||
10.21
|
||
10.22
|
||
10.23
|
||
21.1
|
||
31.1
|
||
31.2
|
||
32.1
|
(1)
|
Filed
as an exhibit to the registrant’s Registration Statement on Form SB-2
filed on March 16, 2005 and incorporated herein by
reference.
|
(2)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
November 11, 2005 and incorporated herein by
reference.
|
(3)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
November 17, 2005 and incorporated herein by
reference.
|
(4)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
January 12, 2006 and incorporated herein by
reference.
|
(5)
|
Filed
as an exhibit to the registrant’s Transition Report on Form 10KSB
filed on June 29, 2006 and incorporated herein by
reference.
|
(6)
|
Filed
as an exhibit to the registrant’s Form 10-QSB for the quarter ended
September 30, 2006 filed on November 15,
2006.
|
(7)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
January 17, 2007 and incorporated herein by
reference.
|
(8)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
July 10, 2007 and incorporated herein by
reference.
|
(9)
|
Filed
as an exhibit to Amendment 2 to the registrant’s registration statement on
Form SB-2 filed on April 16, 2007 and incorporated herein by
reference.
|
(10)
|
Filed
as an exhibit to the registrant’s Current Report on Form 8-K filed on
January 14, 2008 and incorporated herein by
reference
|
(11)
|
Filed
as an exhibit to the registrant’s Transition Report on Form 10K filed
on July 9, 2008 and incorporated herein by
reference.
|
(12)
|
Filed
herein
|
July
10, 2009
|
ANPATH
GROUP, INC.
|
By:
/s/ J. Lloyd
Breedlove
|
|
Name:
J. Lloyd Breedlove
|
|
Title:
President and CEO
|
|
July
10, 2009
|
/s/
J. Lloyd
Breedlove
|
J.
Lloyd Breedlove, President, Chief Executive Officer and Director
(principal executive officer)
|
|
July
10, 2009
|
/s/
Stephen
Hoelscher
|
Stephen
Hoelscher, Chief Financial Officer and Director (principal financial and
accounting officer)
|
|
Year
Ended
|
||||||||
March
31,
|
||||||||
2009
|
2008
|
|||||||
ASSETS
|
||||||||
CURRENT
ASSETS
|
||||||||
Cash
|
$ | 11,231 | $ | 351,627 | ||||
Accounts
receivable, net
|
10,241 | 16,880 | ||||||
Prepaid
expenses
|
4,817 | 96,061 | ||||||
Inventory
|
22,354 | 49,399 | ||||||
TOTAL
CURRENT ASSETS
|
48,643 | 513,967 | ||||||
PROPERTY
AND EQUIPMENT
|
||||||||
Furniture
& fixtures
|
205,694 | 205,694 | ||||||
Machinery
& equipment
|
195,137 | 195,137 | ||||||
Capitalized
software
|
3,210 | 3,210 | ||||||
Less
accumulated depreciation
|
(205,676 | ) | (138,712 | ) | ||||
TOTAL
FIXED ASSETS
|
198,365 | 265,329 | ||||||
OTHER
ASSETS
|
||||||||
Trade
secrets
|
1,026,000 | 1,026,000 | ||||||
Deposits
|
198,082 | 244,338 | ||||||
TOTAL
OTHER ASSETS
|
1,224,082 | 1,270,338 | ||||||
TOTAL
ASSETS
|
$ | 1,471,090 | $ | 2,049,634 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
CURRENT
LIABILITIES
|
||||||||
Accounts
payable and accrued expenses
|
$ | 395,525 | $ | 121,727 | ||||
Accrued
interest payable
|
135,570 | 23,877 | ||||||
Wages
payable
|
188,840 | — | ||||||
Current
maturities of long term debt, net of discount
|
1,484,357 | — | ||||||
TOTAL
CURRENT LIABILITIES
|
2,204,292 | 145,604 | ||||||
LONG
TERM LIABILITIES
|
||||||||
Notes
payable, net of discount
|
— | 250,000 | ||||||
TOTAL
LONG TERM LIABILITIES
|
— | 250,000 | ||||||
TOTAL
LIABILITIES
|
— | 395,604 | ||||||
COMMITMENTS
AND CONTINGENCIES
|
— | — | ||||||
STOCKHOLDERS'
EQUITY
|
||||||||
Preferred
stock, $0.0001 par value; 5,000,000 shares authorized,
|
||||||||
no
shares issued and outstanding
|
— | — | ||||||
Common
stock, $0.0001 par value; 100,000,000 shares authorized,
|
||||||||
16,203,654
and 14,249,889 shares issued and outstanding
|
1,620 | 1,425 | ||||||
Additional
paid-in capital
|
28,863,063 | 27,226,561 | ||||||
Accumulated
deficit
|
(29,597,885 | ) | (25,573,956 | ) | ||||
TOTAL
STOCKHOLDERS' EQUITY
|
(733,202 | ) | 1,654,030 | |||||
TOTAL
LIABILITIES AND
|
||||||||
STOCKHOLDERS'
EQUITY
|
$ | 1,471,090 | $ | 2,049,634 |
Years
Ended
|
||||||||
March
31,
|
||||||||
2009
|
2008
|
|||||||
REVENUES
|
$ | 85,969 | $ | 115,284 | ||||
COST
OF SALES
|
77,612 | 139,537 | ||||||
Gross
Profit
|
8,357 | (24,253 | ) | |||||
EXPENSES
|
||||||||
Sales
|
339,697 | 309,257 | ||||||
Product
development
|
433,556 | 500,106 | ||||||
Corporate
|
729,268 | 1,098,480 | ||||||
Finance
and administrative
|
403,284 | 443,241 | ||||||
Consultants
|
261,375 | 1,010,487 | ||||||
Compensation
cost for re-pricing warrants
|
582,056 | 931,993 | ||||||
Financing
expense
|
1,171,363 | 250,000 | ||||||
Total
Expenses
|
3,920,599 | 4,543,564 | ||||||
LOSS
FROM OPERATIONS
|
(3,912,242 | ) | (4,567,817 | ) | ||||
OTHER
INCOME (EXPENSE)
|
||||||||
Interest
expense
|
(111,693 | ) | (23,877 | ) | ||||
Interest
income
|
6 | 17,742 | ||||||
Impairment
of long lived assets
|
— | (374,000 | ) | |||||
Total
Other Income (Expense)
|
(111,687 | ) | (380,135 | ) | ||||
LOSS
BEFORE TAXES
|
(4,023,929 | ) | (4,947,952 | ) | ||||
INCOME
TAX EXPENSE
|
— | (349 | ) | |||||
NET
LOSS
|
$ | (4,023,929 | ) | $ | (4,948,301 | ) | ||
BASIC
AND DILUTED NET LOSS PER SHARE
|
$ | (0.28 | ) | $ | (0.33 | ) | ||
WEIGHTED
AVERAGE NUMBER OF
|
||||||||
COMMON
SHARES OUTSTANDING,
|
||||||||
BASIC
AND DILUTED
|
14,650,443 | 14,793,058 |
|
Common
Stock
|
Additional
Paid-in
|
Accumulated
|
Total
Stockholders'
|
||||||
Shares
|
Amount
|
Capital
|
(Deficit)
|
Equity
|
||||||
Balance,
March 31, 2007
|
16,299,889
|
$
|
1,630
|
$
|
23,789,948
|
$
|
(20,625,655)
|
$
|
3,165,923
|
|
Common
stock issued at a price of $1.25 per sharein the exercise of
warrants
|
200,000
|
20
|
249,980
|
—
|
250,000
|
|||||
Common
stock issued for services
|
500,000
|
50
|
877,450
|
—
|
877,500
|
|||||
Common
stock surrendered in Settlement Agreement
|
(2,500,000)
|
(250)
|
250
|
—
|
—
|
|||||
Common
stock purchased and held in Treasury
|
(250,000)
|
(25)
|
(624,975)
|
—
|
(625,000)
|
|||||
Stock
options granted and warrants issued
|
—
|
—
|
2,001,915
|
—
|
2,001,915
|
|||||
Warrants
re-priced
|
—
|
—
|
931,993
|
—
|
931,993
|
|||||
Net
loss for the year ended March 31, 2008
|
—
|
—
|
—
|
(4,948,301)
|
(4,948,301)
|
|||||
Balance,
March 31, 2008
|
14,249,889
|
1,425
|
27,226,561
|
(25,573,956)
|
1,654,030
|
|||||
Common
stock issued at a price of $.20 per share in the exercise of
warrants
|
675,000
|
68
|
134,932
|
—
|
135,000
|
|||||
Common
stock issued for services
|
1,165,129
|
116
|
325,886
|
—
|
326,002
|
|||||
Common
stock and warrants issued at a price of $.88 per share for
cash
|
113,636
|
11
|
99,989
|
—
|
100,000
|
|||||
Stock
options granted and warrants issued
|
—
|
—
|
405,079
|
—
|
405,079
|
|||||
Warrants
re-priced for cash at $.20 per warrant
|
—
|
—
|
88,560
|
—
|
88,560
|
|||||
Warrants
re-priced in exchange for services rendered
|
—
|
—
|
582,056
|
—
|
582,056
|
|||||
Net
loss for the year ended March 31, 2009
|
—
|
—
|
—
|
(4,023,929)
|
(4,023,929)
|
|||||
Balance,
March 31, 2009
|
16,203,654
|
$
|
1,620
|
$
|
28,863,063
|
$
|
(29,597,885)
|
$
|
(733,202)
|
Year
Ended
|
||||||||
March
31,
|
||||||||
2009
|
2008
|
|||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||
Net
loss
|
$ | (4,023,929 | ) | $ | (4,948,301 | ) | ||
(Gain)
loss on disposal of assets
|
— | — | ||||||
Depreciation
and amortization
|
66,964 | 54,542 | ||||||
Stock
issued for services
|
326,002 | 877,500 | ||||||
Stock
options granted and warrants issued
|
363,587 | 2,933,908 | ||||||
Warrants
re-priced in exchange for services
|
623,548 | — | ||||||
Financing
expense
|
1,171,363 | 250,000 | ||||||
Adjustments
to reconcile net loss to net cash used by operations:
|
||||||||
Decrease
(increase) in accounts receivable
|
6,639 | 491 | ||||||
Decrease
(increase) in prepaid expenses
|
91,244 | (65,568 | ) | |||||
Decrease
(increase) in inventory
|
27,045 | 48,680 | ||||||
Decrease
in trade secrets
|
— | 374,000 | ||||||
Decrease
(increase) in deposits
|
46,256 | (33,480 | ) | |||||
Increase
(decrease) in accounts payable & accrued
expenses
|
273,798 | 67,170 | ||||||
Increase
(decrease) in accrued interest payable
|
111,693 | — | ||||||
Increase
(decrease) in wages payable
|
188,840 | — | ||||||
Increase
(decrease) in discount on note payable
|
(195,216 | ) | (1,500,000 | ) | ||||
Increase
(decrease) in product recall reserve
|
— | (26,999 | ) | |||||
Net
cash used by operating activities
|
(922,166 | ) | (1,968,057 | ) | ||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||
Purchase
of equipment
|
— | (21,811 | ) | |||||
Net
cash provided (used) in investing activities
|
— | (21,811 | ) | |||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||
Proceeds
from note payable
|
393,210 | 1,500,000 | ||||||
Payments
on notes payable
|
(135,000 | ) | — | |||||
Proceeds
from the re-price of warrants
|
88,560 | — | ||||||
Proceeds
from exercise of warrants
|
100,000 | 250,000 | ||||||
Sale
(Purchase) of common stock
|
135,000 | (625,000 | ) | |||||
Net
cash provided by financing activities
|
581,770 | 628,608 | ||||||
NET
INCREASE (DECREASE) IN CASH
|
(340,396 | ) | (864,868 | ) | ||||
CASH
- Beginning of period
|
351,627 | 1,216,495 | ||||||
CASH
- End of period
|
$ | 11,231 | $ | 351,627 | ||||
SUPPLEMENTAL
CASH FLOW DISCLOSURES:
|
||||||||
Interest
expense
|
$ | — | $ | — | ||||
Income
taxes
|
$ | — | $ | 349 |
March
31,
|
||||||||
2009
|
2008
|
|||||||
Office
Equipment
|
$ | 51,347 | $ | 51,347 | ||||
Furniture
& Fixtures
|
11,825 | 11,825 | ||||||
Marketing/Trade
Shows
|
2,659 | 2,659 | ||||||
Manufacturing
Equipment
|
195,138 | 195,138 | ||||||
Laboratory
Equipment
|
139,138 | 118,051 | ||||||
Capitalized
Software
|
3,210 | 3,210 | ||||||
382,230 | 382,230 | |||||||
Allowance
for Depreciation
|
( 205,676 | ) | (138,712 | ) | ||||
Fixed
Assets, net
|
$ | 198,365 | $ | 265,329 |
|
March
31,
|
|||||||
2009
|
2008
|
|||||||
Raw
material
|
$ | 22,354 | $ | 36,540 | ||||
Work-in-progress
|
— | — | ||||||
Finished
goods
|
— | 12,859 | ||||||
Inventory,
net
|
$ | 22,354 | $ | 43,399 |
March
31,
|
||||||||
2009
|
2008
|
|||||||
Net
operating loss carryforward:
|
$ | 29,598,000 | $ | 25,574,000 | ||||
Deferred
tax asset
|
$ | 10,063,000 | $ | 8,695,000 | ||||
Deferred
tax asset valuation allowance
|
(10,063,000 | ) | (8,695,000 | ) | ||||
Net
deferred tax asset
|
$ | — | $ | — |
March
31,
|
||||||||
2009
|
2008
|
|||||||
7%
note due July 8, 2010 payable to ANPG Lending, LLC
|
$ | 1,500,000 | $ | 1,500,000 | ||||
6%
notes due on or before May 10, 2009 payable to our CEO
|
102,210 | - | ||||||
6%
notes due on or before February 24, 2009 payable to Arthur Douglas &
Associates
|
85,000 | - | ||||||
6%
notes due December 29, 2008 payable to our CFO
|
6,000 | - | ||||||
10%
note due April 8, 2009 payable to an unrelated individual
|
25,000 | - | ||||||
10%
note due June 10, 2009 payable to an unrelated individual
|
20,000 | - | ||||||
10%
note due June 24, 2009 payable to an unrelated individual
|
20,000 | - | ||||||
Discount
on notes payable
|
(273,853 | ) | (1,250,000 | ) | ||||
$ | 1,484,357 | $ | 250,000 |
|
Payments
Due by Period
|
|||||||||||||||||||
Contractual Obligations
|
Total
|
Less
than
1
year
|
1-3
years
|
4-5
years
|
After
5
years
|
|||||||||||||||
Office
Lease
|
$ | 35,400 | $ | 35,400 | — | — | — | |||||||||||||
Laboratory
Lease (1)
|
— | — | — | — | — | |||||||||||||||
Total
Contractual Cash Obligations
|
$ | 35,400 | $ | 35,400 | — | — | — |
Number
of
Shares
Under
Warrants
|
Exercise
Price
Per
Share
|
Weighted
Average
Exercise
Price
|
||||||||||
Warrants
issued and exercisable at:
March
31, 2007
|
4,713,533 | $ | 2.50-5.00 | $ | 2.89 | |||||||
Warrants
issued
|
4,250,000 | 0.87 – 2.70 | 1.97 | |||||||||
Warrants
expired
|
(823,191 | ) | 5.00 | 5.00 | ||||||||
Warrants
exercised
|
(200,000 | ) | 1.25 | 1.25 | ||||||||
Warrants
issued and exercisable at:
March
31, 2008
|
7,940,342 | $ | 0.87-5.00 | $ | 2.25 | |||||||
Warrants
issued
|
626,600 | 0.87-2.70 | 1.97 | |||||||||
Warrants
expired
|
(248,928 | ) | 5.00 | 5.00 | ||||||||
Warrants
exercised
|
(675,000 | ) | 0.20 | 0.20 | ||||||||
Warrants
issued and exercisable at:
March
31, 2009
|
7,643,014 | $ | 0.20-5.00 | $ | 2.25 |
Outstanding
and Exercisable
|
|||||||||
Range
of Exercise Price
|
Number
of
Shares
Under
Warrants
|
Weighted
Average
Remaining
Contract
Life in
Years
|
Weighted
Average
Exercise
Price
|
||||||
$0.20
- 5.00
|
641,414
|
0.77
|
$
|
2.38
|
|||||
$0.20
- 2.50
|
2,125,000
|
1.03
|
0.95
|
||||||
$0.20
- 2.70
|
4,250,000
|
3.42
|
1.97
|
||||||
$0.20
– 0.88
|
626,600
|
4.52
|
0.56
|
||||||
7,643,014
|
2.62
|
$
|
1.55
|
Shares
Under
Options
Outstanding
|
Weighted
Average
Exercise
Price
|
|||||||
Options
outstanding at March 31, 2007
|
2,578,255 | $ | 2.73 | |||||
Options
granted
|
98,200 | 1.75 | ||||||
Options
expired
|
— | — | ||||||
Options
exercised
|
— | — | ||||||
Options
outstanding at March 31, 2008
|
2,676,455 | 2.75 | ||||||
Options
granted
|
42,000 | 0.63 | ||||||
Options
expired or canceled
|
(1,169,903 | ) | 3.01 | |||||
Options
exercised
|
— | — | ||||||
Options
outstanding at March 31, 2009
|
1,548,552 | $ | 2.49 |
Options
Exercisable
|
Weighted
Average
Exercise
Price
per
Share
|
|||||||
Options
exercisable at March 31, 2008
|
2,298,955 | $ | 2.75 | |||||
Options
exercisable at March 31, 2009
|
1,548,552 | $ | 2.49 |
Range
of
Exercise
Price
|
Number
Outstanding
at
March
31,
2009
|
Weighted
Average
Remaining
Contractual
Life
Years
|
Weighted
Average
Exercise
Price
(Total
Shares)
|
Number
Exercisable
At
March
31,
2009
|
Weighted
Average
Exercise
Price
(Exercisable
Shares)
|
|||||||||||||||||
$ | 3.40 | 63,854 | 5.59 | $ | 3.40 | 63,854 | $ | 3.40 | ||||||||||||||
$ | 5.00 | 72,333 | 1.64 | $ | 5.00 | 72,333 | $ | 5.00 | ||||||||||||||
$ | 1.61 - 2.95 | 22,365 | 7.21 | $ | 2.06 | 22,365 | $ | 2.06 | ||||||||||||||
$ | 2.00 - 2.85 | 1,390,000 | 4.30 | $ | 2.32 | 1,217,500 | $ | 2.34 | ||||||||||||||
$ | 1.61 - 5.00 | 1,548,552 | 4.27 | $ | 2.49 | 1,376,052 | $ | 2.53 |